Disease: Carcinoma, Ovarian Epithelial ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.080 AlteredExpression disease BEFREE High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum. 31154673 2019
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.080 GeneticVariation disease BEFREE We analysed the role of germline EMSY variation in breast/ovarian cancer predisposition. 28738860 2017
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.080 Biomarker disease BEFREE EMSY links the BRCA2 pathway to sporadic breast/ovarian cancer. 21409565 2011
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.080 AlteredExpression disease BEFREE Expression of EMSY gene in sporadic ovarian cancer. 20349280 2011
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.080 Biomarker disease BEFREE In summary, amplification of these four putative oncogenes from 11q13 in early ovarian cancer is associated with a serous histology and in the case of EMSY and RSF1 a poor outcome. 18314909 2008
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.080 Biomarker disease BEFREE These findings support the role of EMSY as a key oncogene within the 11q13 amplicon in ovarian cancer. 16236351 2006
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.080 GeneticVariation disease BEFREE We found no association between common genetic variation in EMSY and risk of breast or ovarian cancer in two large study sets of white British women. 16029503 2005
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.080 GeneticVariation disease BEFREE The remarkable clinical overlap between sporadic EMSY amplification and familial BRCA2 deletion implicates a BRCA2 pathway in sporadic breast and ovarian cancer. 14651845 2003